Symbio Generrics India Private
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $13M
Investors
- 1
About Symbio Generrics India Private
Based in Karnataka, India, and founded in 2010, Symbio Generrics India Private Limited operates as a manufacturer of pharmaceutical products. The company manufactures and markets intermediates and active pharmaceutical ingredients (APIs) in IP (Indian Pharmacopoeia), BP (British Pharmacopoeia) and USP (United State Pharmacopoeia) standards for emerging and regulated markets. The company with reaction and processing capabilities including hydrogenation, high-temperature reactions, gas purging etc. also offers contract development and manufacturing (CDMO) services.
Who invested in Symbio Generrics India Private
1 investor across 1 round
See all investors in Symbio Generrics India Private
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 3, 2022
Amount
$13M
Investors
Questions about Symbio Generrics India Private
Who invested in Symbio Generrics India Private?
Symbio Generrics India Private has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Symbio Generrics India Private raised?
Symbio Generrics India Private has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Symbio Generrics India Private last raise money?
Symbio Generrics India Private's most recent round on record is a Series B, in Mar 2022.
What does Symbio Generrics India Private do?
Based in Karnataka, India, and founded in 2010, Symbio Generrics India Private Limited operates as a manufacturer of pharmaceutical products.
Where is Symbio Generrics India Private headquartered?
Symbio Generrics India Private is headquartered in Bangalore, India.
Which VCs invest in companies like Symbio Generrics India Private?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Symbio Generrics India Private's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Symbio Generrics India Private? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.